News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,356 Results
Type
Article (7481)
Company Profile (44)
Press Release (175824)
Multimedia
Podcasts (49)
Webinars (8)
Section
Business (51200)
Career Advice (469)
Deals (9936)
Drug Delivery (50)
Drug Development (22244)
Employer Resources (51)
FDA (4300)
Job Trends (5121)
News (87396)
Policy (8283)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (935)
Academic (1)
Accelerated approval (11)
Adcomms (4)
Allergies (65)
Alliances (10529)
ALS (81)
Alzheimer's disease (743)
Antibody-drug conjugate (ADC) (89)
Approvals (4530)
Artificial intelligence (233)
Autoimmune disease (64)
Automation (12)
Bankruptcy (75)
Best Places to Work (4714)
BIOSECURE Act (10)
Biosimilars (67)
Biotechnology (28)
Bladder cancer (82)
Brain cancer (16)
Breast cancer (249)
Cancer (1793)
Cardiovascular disease (176)
Career advice (413)
Career pathing (17)
CAR-T (66)
CDC (8)
Cell therapy (209)
Cervical cancer (17)
Clinical research (20253)
Collaboration (664)
Compensation (167)
Complete response letters (14)
COVID-19 (816)
CRISPR (37)
C-suite (357)
Cystic fibrosis (44)
Data (2920)
Decentralized trials (1)
Denatured (16)
Depression (52)
Diabetes (218)
Diagnostics (2309)
Digital health (15)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (92)
Drug pricing (84)
Drug shortages (7)
Duchenne muscular dystrophy (115)
Earnings (29032)
Editorial (19)
Employer branding (4)
Employer resources (45)
Events (24170)
Executive appointments (409)
FDA (5823)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (644)
Gene editing (65)
Generative AI (21)
Gene therapy (225)
GLP-1 (287)
Government (1545)
Grass and pollen (2)
Guidances (315)
Healthcare (6293)
HIV (35)
Huntington's disease (10)
IgA nephropathy (29)
Immunology and inflammation (56)
Immuno-oncology (12)
Indications (44)
Infectious disease (930)
Inflammatory bowel disease (81)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (88)
Interviews (63)
IPO (5427)
IRA (26)
Job creations (693)
Job search strategy (322)
JPM (22)
Kidney cancer (3)
Labor market (29)
Layoffs (155)
Leadership (19)
Legal (1368)
Liver cancer (27)
Longevity (8)
Lung cancer (218)
Lymphoma (146)
Machine learning (20)
Management (22)
Manufacturing (279)
MASH (98)
Medical device (4261)
Medtech (4287)
Mergers & acquisitions (5000)
Metabolic disorders (530)
Multiple sclerosis (79)
NASH (7)
Neurodegenerative disease (125)
Neuropsychiatric disorders (31)
Neuroscience (1284)
Neurotech (1)
NextGen: Class of 2026 (1743)
Non-profit (2269)
Now hiring (5)
Obesity (208)
Opinion (118)
Ovarian cancer (59)
Pain (69)
Pancreatic cancer (100)
Parkinson's disease (130)
Partnered (20)
Patents (136)
Patient recruitment (173)
Peanut (21)
People (13076)
Pharmaceutical (14)
Pharmacy benefit managers (11)
Phase 1 (5357)
Phase 2 (8786)
Phase 3 (7713)
Pipeline (2518)
Policy (123)
Postmarket research (704)
Preclinical (2114)
Press Release (10)
Prostate cancer (102)
Psychedelics (10)
Radiopharmaceuticals (84)
Rare diseases (355)
Real estate (813)
Recruiting (19)
Regulatory (7050)
Reports (17)
Research institute (827)
Resumes & cover letters (83)
Rett syndrome (21)
RNA editing (3)
RSV (36)
Schizophrenia (69)
Series A (93)
Series B (76)
Service/supplier (2)
Sickle cell disease (38)
Special edition (7)
Spinal muscular atrophy (51)
Sponsored (24)
Startups (734)
State (1)
Stomach cancer (3)
Supply chain (33)
Tariffs (55)
The Weekly (32)
Vaccines (327)
Venture capital (25)
Weight loss (102)
Women's health (40)
Worklife (10)
Date
Today (49)
Last 7 days (234)
Last 30 days (779)
Last 365 days (11649)
2026 (1264)
2025 (11671)
2024 (13379)
2023 (15417)
2022 (21154)
2021 (22515)
2020 (20197)
2019 (13142)
2018 (9536)
2017 (7294)
2016 (6559)
2015 (7122)
2014 (4743)
2013 (3541)
2012 (3745)
2011 (4038)
2010 (3336)
Location
Africa (187)
Alabama (50)
Alaska (4)
Arizona (75)
Arkansas (3)
Asia (10155)
Australia (1333)
California (4085)
Canada (1244)
China (343)
Colorado (182)
Connecticut (172)
Delaware (119)
Europe (22944)
Florida (591)
Georgia (116)
Hawaii (2)
Idaho (17)
Illinois (362)
India (24)
Indiana (219)
Iowa (7)
Japan (173)
Kansas (21)
Kentucky (10)
Louisiana (15)
Maine (42)
Maryland (483)
Massachusetts (3023)
Michigan (128)
Minnesota (213)
Missouri (69)
Montana (6)
Nebraska (4)
Nevada (43)
New Hampshire (48)
New Jersey (1261)
New Mexico (3)
New York (1382)
North Carolina (493)
North Dakota (4)
Northern California (1984)
Ohio (144)
Oklahoma (9)
Oregon (17)
Pennsylvania (883)
Puerto Rico (13)
Rhode Island (13)
South America (287)
South Carolina (20)
Southern California (1642)
Tennessee (88)
Texas (594)
United States (15107)
Utah (103)
Vermont (1)
Virginia (90)
Washington D.C. (33)
Washington State (349)
West Virginia (1)
Wisconsin (40)
183,356 Results for "impact biomedicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
January 29, 2026
·
4 min read
Press Releases
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer
January 13, 2026
·
3 min read
Press Releases
Fortitude Biomedicines Launches With $13M in Financing to Advance Novel Antibody-based Therapies for Treatment of Autoimmune Diseases and Cancer
January 27, 2026
·
4 min read
Press Releases
Force Therapeutics Celebrates 2025 Research Impact
January 9, 2026
·
2 min read
Job Trends
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
The Trump administration’s recently announced fee for new H-1B visa petitions is “completely unreasonable,” an immigration attorney told
BioSpace
. Attorneys and talent acquisition experts discuss how the fee could impact biopharma and confusion around the proclamation.
September 25, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
February 11, 2026
·
2 min read
Press Releases
Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research
February 12, 2026
·
4 min read
Press Releases
AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships
January 29, 2026
·
5 min read
Press Releases
Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
January 16, 2026
·
6 min read
Press Releases
Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer
November 5, 2025
·
2 min read
1 of 18,336
Next
